The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma

Journal of the American Dental Association

Volumn 143, Issue 12, 2012, Pages 1332-1342

  Epstein, Joel B ^a   Güneri, Pelin ^b   Boyacioglu, Hayal ^b   Abt, Elliot ^c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b EGE UNIVERSITY   (Turkey)

^c ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

Author keywords

Mouth diseases; Mouth neoplasms; Oral cancer; Oral diagnosis; Precancerous conditions

Indexed keywords

EID: 84871791219     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2012.0096     Document Type: Article

References (65)

1. Wamakulasuriya KA, Ekanayake AN, Sivayoham S, et al. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ 1984;62(2):243-250. (Pubitemid 14113758)
2. Boyle P, Autier P, Bartelink H, et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 2003;14(7):973-1005. (Pubitemid 36950159)
3. Epstein JD, Knight TK, Epstein JB, Bride MA, Nichol MB. Cost of care for early-and late-stage oral and pharyngeal cancer in the California Medicaid population. Head Neck 2008;3(K2):178-186. (Pubitemid 351251700)
4. Seoane J, Wamakulasuriya S, Varela-Centelles P, Esparza G, Dios PD. Oral cancer: experiences and diagnostic abilities elicited by dentists in North-western Spain. Oral Dis 2006;12(5):487-492. (Pubitemid 44252542)
5. Epstein JB, Villines D, Drahos G, Kaufman E, Gorsky M. Oral lesions in patients participating in an oral examination screening week at an urban dental school. JADA 2008;139(10):1338-1344.
6. National Cancer Institute, Surveillance Epidemiology and End Results. SEER Stat fact sheets: oral cavity and pharynx, www.seer.cancer.gov/statfacts/ html/oralcav. html#survival. Accessed Oct. 3, 2012.
7. Rethman MP, Carpenter W, Cohen EE, et al: American Dental Association Council on Scientific Affairs Expert Panel on Screening for Oral Squamous Cell Carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. JADA 2010;141(5):509-520.
8. Epstein JB, Gorsky M, Cabay RJ, Day T, Gonsalves W. Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians. Can Fam Physician 2008;54(6):870-875. (Pubitemid 352045138)
9. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue (published online ahead of print Nov. 8, 2007;. Oral Oncol 2008;44(6):538-544. doi:10.1016V j.oraloncology.2007.08.011. (Pubitemid 351681969)
10. published correction appears in Oral Oncol 2008;44 [6]: 615)
11. Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 2004;35(5):378-384. (Pubitemid 38515509)
12. Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 2006;17(3):59-63. (Pubitemid 44432882)
13. Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions (published online ahead of print Dec. 13, 2006). Oral Oncol 2007;43(8):820-824. doi:10.1016/j.oraloncology.2006. 10.005. (Pubitemid 47259448)
14. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53(1):5-26. (Pubitemid 36163619)
15. Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg J J. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986;9(3-4):219-225.
16. Wamakulasuriya S, Pindborg JJ. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health 1990;7(1):73-79.
17. Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol 1991;19(3):160-163.
18. Downer MC, Evans AW, Hughes Hallet CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol 1995;23(2):84-88.
19. Ikeda N, Downer MC, Ishii T, Fukano H, Nagao T, Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dent Health 1995;12(3):133-137.
20. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health 1995;12(1):3-7.
21. Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer 1997;76(3):390-394. (Pubitemid 27308092)
22. Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Wamakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol 2000;36(4):340-346. (Pubitemid 30427254)
23. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 2007;65(3):424-426. (Pubitemid 46329245)
24. Morse DE, Psoter WJ, Cuadrado L, et al. A deficit in biopsying potentially premalignant oral lesions in Puerto Rico (published online ahead of print Feb. 27, 2009). Cancer Detect Prev 2009;32(5-6):424-430. doi:10.1016/j.cdp. 2009.01.004.
25. Su WW, Yen AM, Chiu SY, Chen TH. A community-based RCT for oral cancer screening with toluidine blue (published online ahead of print June 4, 2010). J Dent Res 2010;89(9):933-937. doi:10.1177/0022034510373763.
26. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
27. Onofre MA, Sposto MR, Navarro CM, Motta ME, Turatti E, Almeida RT. Potentially malignant epithelial oral lesions: discrepancies between clinical and histological diagnosis. Oral Dis 1997;3(3):148-152. (Pubitemid 27438813)
28. Prout MN, Sidari JN, Witzburg RA, Grillone GA, Vaughan CW. Head and neck cancer screening among 4611 tobacco users older than forty years. Otolaryngol Head Neck Surg 1997;116(2):201-208. (Pubitemid 27097546)
29. Zheng W, Soo KC, Sivanandan R, Olivo M. Detection of squamous cell carcinomas and pre-cancerous lesions in the oral cavity by quantification of 5-aminolevulinic acid induced fluorescence endoscopic images. Lasers Surg Med 2002;31(3):151-157.
30. Epstein JB, Feldman R, Dolor RJ, Porter SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003;25(11):911-921. (Pubitemid 37323006)
31. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95(1):45-50. (Pubitemid 36886721)
32. Remmerbach TW, Weidenbach H, Muller C, et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol 2003;25(3):139-146. (Pubitemid 36693700)
33. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 2004;33(7):398-404. (Pubitemid 38988194)
34. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions (published online ahead of print Jan. 26, 2005). Int J Oral Maxillofac Surg 2005;34(5):521-527. doi:10.10167j.ijom.2004.10.008. (Pubitemid 40790349)
35. Chen YW, Lin JS, Fong JH, et al. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions (published online ahead of print Nov. 1, 2006). Br J Oral Maxillofac Surg 2007;45(7):590-591. doi:10.1016/j.bjoms.2006.08.017. (Pubitemid 47398699)
36. Du GF, Li CZ, Chen HZ, et al. Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: a pilot study. Int J Cancer 2007;120(9):1958-1963.
37. Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma (published online ahead of print June 11, 2008). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(3):371-376. doi:10.1016/j.tripleo. 2008.01.017.
38. Mehrotra R, Singh MK, Pandya S, Singh M. The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients (published correction appears in Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106[4]:621). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(2):246-253.
39. Allegra E, Lombardo N, Puzzo L, Garozzo A. The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. Acta Otorhinolaryngol Ital 2009;29(4):187-190.
40. Arduino PG, Surace A, Carbone M, et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up (published online ahead of print May 18, 2009). J Oral Pathol Med 2009;38(6):540-544. doi:10.1111/j. 1600-0714.2009. 00782.x.
41. Mcintosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions (published online ahead of print Oct. 1, 2009). Oral Oncol 2009;45(12):e227-e231. doi:10.1016V j.oraloncology.2009.08.001.
42. Wilder-Smith P, Lee K, Guo S, et al. In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients. Lasers Surg Med 2009;41(5):353-357.
43. Jerjes W, Upile T, Conn B, et al. In vitro examination of suspicious oral lesions using optical coherence tomography (published online ahead of print Sept. 1, 2009). Br J Oral Maxillofac Surg 2010;48(1):18-25. doi:10.1016/j.bjoms. 2009.04.019.
44. Mehrotra R, Singh M, Thomas S, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions (published correction appears in JADA 2010;141[4]:388). JADA 2010;141(2):151-156.
45. Nagaraju K, Prasad S, Ashok L. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions. Indian J Dent Res 2010;21(2):218-223.
46. Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions (published online ahead of print Nov. 26, 2010). Int J Oral Maxillofac Surg 2011;40(2):155-161. doi:10.1016/j.rjom.2010.10.022.
47. Koch FP, Kunkel M, Biesterfeld S, Wagner W. Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity: a prospective and blinded study (published online ahead of print July 1, 2010). Clin Oral Investig 2011;15(5):763-769. doi:10.1007/s00784-010-0434-6.
48. Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W. Effectiveness of autofluorescence to identify suspicious oral lesions: a prospective, blinded clinical trial (published online ahead of print Aug. 17, 2010). Clin Oral Investig 2011;15(6):975-982. doi:10.1007/S00784-010-0455-1.
49. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56(11):1129-1135. (Pubitemid 37386338)
50. Jones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 2005;79(1):16-20. (Pubitemid 40037431)
51. Rosman AS, Korsten MA. Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing. Adv Med Sci 2007;52:76-82.
52. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6:31.
53. Westra WH, Sidransky D. Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin Cancer Res 2006;12(22):6594-6597. (Pubitemid 44876825)
54. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of literature. JADA 2008;139(7):896-905.
55. Seoane Leston J, Diz Dios P. Diagnostic clinical aids in oral cancer (published online ahead of print April 3, 2010). Oral Oncol 2010;46(6):418-422. doi:10.1016Vj.oraloncology.2010.03.006.
56. Balevi B. Assessing the usefulness of three adjunctive diagnostic devices for oral cancer screening: a probabilistic approach (published online ahead of print Oct. 5, 2010). Community Dent Oral Epidemiol 2011;39(2):171-176. doi:10.1111/j.1600-0528.2010.00579.x.
57. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323(7305):157-162. (Pubitemid 32678396)
58. Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra WH, Koch D, Sidransky D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res 2001;7(7):1963-1968. (Pubitemid 32994832)
59. Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65(17):8017-8021. (Pubitemid 41297282)
60. Thomson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 2002;31(3):262-266.
61. Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. J Oral Pathol Med 2004;33(2):65-70. (Pubitemid 38166425)
62. Fischer DJ, Epstein JB. Management of patients who have undergone head and neck cancer therapy. Dent Clin North Am 2008;52(1):39-60, viii.
63. Holmes JD, Dierks EJ, Homer LD, Potter BE. Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis? J Oral Maxillofac Surg 2003;61(3):285-291. (Pubitemid 36268373)
64. Le Hew C, Epstein JB, Koerber A, Kaste LM. Training in the primary prevention and early detection of oral cancer: pilot study of its impact on clinicians' perceptions and intentions. Ear Nose Throat J 2009;88(1):748-753.
65. Le Hew CW, Epstein JB, Kaste L, Choi YK. Assessing oral cancer early detection: clarifying dentists' practices. J Public Health Dent 2010;70(2):93-100.